Goeltz II Robert C.
Chief Financial Officer
Goeltz II Robert C. has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: May 12, 2026.
On the most recent filing, Goeltz II Robert C. is listed as Chief Financial Officer at Arcus Biosciences, Inc. Inside the rolling window, Goeltz II Robert C. reported no open-market purchases and 5 open-market sales totaling $756K in RCUS. The largest disclosed transaction in the window is a sale of 7,763 RCUS shares on May 11, 2026, worth $199K.
Companies traded
Other insiders at RCUS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$756K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 28, 2025 | RCUS | Sale | $100K |
Frequently asked questions
How many SEC Form 4 filings has Goeltz II Robert C. made?
Goeltz II Robert C. has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Goeltz II Robert C. trade?
Goeltz II Robert C. has filed SEC Form 4 disclosures for 1 company, including RCUS.
When was Goeltz II Robert C.'s most recent SEC Form 4 filing?
Goeltz II Robert C.'s most recent SEC Form 4 filing on Tracefour is dated May 12, 2026.
What is Goeltz II Robert C.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Goeltz II Robert C. is listed as Chief Financial Officer.
What is Goeltz II Robert C.'s total buy and sell value in the current window?
Inside the rolling retention window, Goeltz II Robert C. bought $0 and sold $756K based on SEC Form 4 filings.
What was Goeltz II Robert C.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,763 RCUS shares on 2026-05-11, worth $199K, per SEC Form 4 filings.